PTPN13 and colonic neoplasm: Using immunohistochemistry, we demonstrated FAP-1 expression in more than 70% of colon cancers, concurring with the immunohistochemical localisation of FAP-1 in a large panel of cancers of various origins, including colon, lung, and breast carcinomas, reported by Lee et al (1999b).